Fushun Kou
Beijing University of Chinese Medicine
14 Papers
6 Citations
Fushun Kou is an academic researcher from Beijing University of Chinese Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 8 publications.
Chat about Author
Papers
Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
Yuan Cheng,Jiali Liu,Xiang Tan,Yi Dai,Chune Xie,Xiaohong Li,Qiongqiong Lu,Fushun Kou,Hui Jiang,Junxiang Li +9 more
TL;DR: It is suggested that vonoprazan is non-inferior to PPIs as therapy for patients with GERD, and subgroup analysis indicates that vonopsion is more effective than PPIs for patientsWith severe erosive esophagitis.
71
Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses.
Lei Shi,Xiao Han,Junxiang Li,Yu-Ting Liao,Fushun Kou,Zhibin Wang,Rui Shi,Xingjie Zhao,Zhongmei Sun,Yu Hao +9 more
TL;DR: Core DEGs identified in UC are related to inflammation and immunity inflammation, indicating that these reactions are core features of the pathogenesis of UC.
30
Systematic assessment of environmental factors for gastroesophageal reflux disease: An umbrella review of systematic reviews and meta-analyses.
TL;DR: An umbrella review of the association between environmental factors and gastroesophageal reflux disease (GERD) found varying levels of evidence for different environmental factors of GERD and none of them was proven to be convincing or highly recommended.
12
Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway.
Xiang Tan,Wenjing Pei,Chun-E Xie,Zhibin Wang,Jiali Liu,Yuan Cheng,Tangyou Mao,Lei Shi,Xingjie Zhao,Qiongqiong Lu,Zhongmei Sun,Fushun Kou,Hui Jiang,Junxiang Li +13 more
TL;DR: In this paper, Tongxie Anchang Decoction (TXACD) has been proved to significantly improve abdominal pain in patients with Irritable Bowel Syndrome (IBS-D), but its underlying therapeutic mechanism still remains unclear.
Network Pharmacology Identifies the Mechanisms of Action of Tongxie Anchang Decoction in the Treatment of Irritable Bowel Syndrome with Diarrhea Predominant.
Xiang Tan,Wenjing Pei,Chune Xie,Zhibin Wang,Tangyou Mao,Xingjie Zhao,Fushun Kou,Qiongqiong Lu,Zhongmei Sun,Xiao-Xuan Xue,Junxiang Li +10 more
TL;DR: The possible mechanisms by which TXACD treatment alleviated IBS-D involvement in the modulation of multiple targets and multiple pathways, including the immune regulation, inflammatory response, and oxidative stress are revealed.